Search / 211 results found

from
to
  • Updated

SANTA CRUZ, Calif., Jan. 19, 2022 /PRNewswire/ -- Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has granted it a Breakthrough Device Designation for its Patho-Seq assay.

  • Updated

SAN FRANCISCO, Jan. 19, 2022 /PRNewswire/ -- Carrum Health, the first digital health company connecting employers and employees to Centers of Excellence (COEs) through a technology-powered platform, today announced a leap forward with its industry-leading quality algorithm to help patients make well-informed decisions when selecting surgeons. Combining its seven years of real-world patient outcome data with comprehensive commercial claims, clinical and Medicare data sets, integrated with a machine learning platform, Carrum Health can now offer unprecedented insights into the three most impactful aspects of quality: appropriateness, functional outcomes and traditional readmission/complication metrics.

  • Updated

REDWOOD CITY, Calif., Jan. 19, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced receipt of FDA approval for expanded labeling for its Senza® Spinal Cord Stimulation (SCS) System for the treatment of Non-Surgical Refractory Back Pain (NSRBP).  This approval is specific to Nevro's proprietary 10 kHz Therapy and differentiates Nevro's Senza System as the only SCS system with specific labeling to treat NSRBP patients.

  • Updated

TUESDAY, Jan. 18, 2022 (HealthDay News) -- Real-world data show steady improvement in overall survival (OS) for patients with Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL) who experienced relapse after allogeneic hematopoietic cell transplantation (allo-HCT), according to a study published online Jan. 12 in Clinical Cancer Research.

  • Updated

MENLO PARK, Calif., Jan. 18, 2022 /PRNewswire/ -- Ajax Health has announced the appointments of two of the most respected cardiovascular professionals to Cordis-X, an independent accelerator created to drive innovation and growth to Cordis. Cordis is a storied medical device brand with global reach that was acquired from Cardinal Health last year by Hellman & Friedman, KKR, and Ajax Health. 

  • Updated

TUESDAY, Jan. 18, 2022 (HealthDay News) -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published in the January issue of Practical Radiation Oncology, recommendations are presented for the use of external beam radiation therapy (EBRT) for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC).

  • Updated

TUESDAY, Jan. 18, 2022 (HealthDay News) -- Presence of an appendicolith is associated with a nearly twofold increased risk for undergoing appendectomy within 30 days of initiating antibiotics for appendicitis, according to a study published online Jan. 12 in JAMA Surgery.